Fredun Pharmaceuticals
add_icon

Fredun Pharmaceuticals

1,303.50
+25.30
(1.98%)
Market Cap
2,155.74 Cr
PE Ratio
48.25
Volume
65,181.00
Day High - Low
1,324.00 - 1,288.10
52W High-Low
1,590.00 - 1,195.20
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
2,155.74 Cr
EPS
66.81
PE Ratio
48.25
PB Ratio
7.86
Book Value
162.78
EBITDA
94.50
Dividend Yield
0.02 %
Industry
Healthcare
Return on Equity
11.73
Debt to Equity
0.93
Forecast For
Actual

Company News

View All News
Caret
positive
Fredun Pharma acquires Furlicks, enters pet wellnessSep 08, 2026
Fredun Pharmaceuticals acquires Furlicks brand from USV and Wellbeing Nutrition, marking its strategic entry into the pet wellness market with plans to launch 12 new SKUs in the first phase.
neutral
Fredun Pharmaceuticals Limited equity shares are permitted to trade on the National Stock Exchange of India Limited effective August 17, 2026, following regulatory approval.
positive
Fredun Pharmaceuticals posted Q1 FY27 standalone total income of ₹228.25 crore, up 90.44% YoY. Net profit rose 94.63% YoY to ₹13.17 crore; EBITDA grew 92.90% YoY to ₹32.78 crore.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,837.30
#1 4,40,829.81
36.95
#1 61,673.90
12.69
#1 11,565
26.53
37.25
9,375.00
2,48,876.79
84.83
11,067.00
13.95
2,568
65.50
63.02
4,840.00
1,84,098.04
86.29
13,886.20
20.34
2,138
3.28
44.60
1,160.00
1,16,723.14
24.70
27,657.90
17.64
5,026
-34.90
55.72
1,394.50
1,12,654.03
33.03
29,044.60
2.24
3,870
-39.18
48.20
1,954.00
1,05,487.98
96.95
6,867.80
22.01
890
#1 123.93
62.24
1,734.00
99,770.53
26.11
34,145.20
5.56
3,503
25.21
63.24
1,185.00
98,908.28
30.73
35,058.60
3.90
4,158
-69.10
55.07
2,083.00
95,241.54
#1 17.23
29,038.90
#1 26.75
5,356
16.00
35.08
2,300.70
95,017.98
45.84
14,636.40
14.85
1,938
29.13
43.18

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
40.06 %
Net Income Growth
65.48 %
Cash Flow Change
171.69 %
ROE
-15.97 %
ROCE
-20.13 %
EBITDA Margin (Avg.)
22.94 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
0
0
286
165
119
144
160
210
228
Expenses
0
0
251
150
103
123
135
184
196
EBITDA
0
0
35
15
17
21
25
26
32
Operating Profit %
0 %
0 %
12 %
9 %
14 %
14 %
16 %
12 %
14 %
Depreciation
0
0
3
2
1
2
2
3
4
Interest
0
0
14
8
7
8
11
15
9
Profit Before Tax
0
0
20
7
9
13
14
11
21
Tax
0
0
7
1
2
3
4
1
7
Net Profit
0
0
14
6
7
9
11
11
13
EPS in ₹
0.00
0.00
29.09
12.71
14.33
19.98
22.19
19.70
23.82

Balance Sheet

Balance Sheet
2025
2026
Total Assets
487
642
Fixed Assets
53
118
Current Assets
427
498
Capital Work in Progress
0
0
Investments
2
2
Other Assets
433
522
Total Equity & Liabilities
487
642
Current Liabilities
328
297
Non Current Liabilities
18
67
Total Equity
141
278
Reserve & Surplus
137
259
Share Capital
5
6

Cash Flow

Cash Flow
2025
2026
Net Cash Flow
4
60
Investing Activities
-6
-74
Operating Activities
-17
12
Financing Activities
27
121

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
May 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Feb 2026
Mar 2026
Jun 2026
Jul 2026
Promoter
52.04 %
52.04 %
52.04 %
51.27 %
51.27 %
51.27 %
51.04 %
51.04 %
50.34 %
50.15 %
49.62 %
49.62 %
49.33 %
49.31 %
49.16 %
49.17 %
48.92 %
49.17 %
48.93 %
48.93 %
48.93 %
48.93 %
48.93 %
43.06 %
43.06 %
44.17 %
44.57 %
44.57 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.46 %
1.06 %
1.06 %
1.06 %
1.06 %
DIIs
1.88 %
1.88 %
1.88 %
1.69 %
1.69 %
1.69 %
1.68 %
1.68 %
1.66 %
1.65 %
1.64 %
1.64 %
1.61 %
1.60 %
1.60 %
1.60 %
1.59 %
1.60 %
1.59 %
1.59 %
1.59 %
1.59 %
1.60 %
3.48 %
2.89 %
2.83 %
2.94 %
2.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
41.01 %
40.99 %
40.77 %
41.56 %
41.90 %
41.81 %
42.02 %
42.08 %
42.48 %
43.07 %
43.64 %
43.60 %
43.48 %
43.49 %
43.67 %
44.02 %
43.94 %
43.89 %
44.21 %
44.55 %
44.50 %
44.52 %
43.74 %
45.18 %
45.63 %
44.66 %
43.79 %
43.62 %
Others
5.07 %
5.09 %
5.32 %
5.47 %
5.13 %
5.23 %
5.25 %
5.19 %
5.52 %
5.13 %
5.10 %
5.14 %
5.58 %
5.60 %
5.58 %
5.22 %
5.55 %
5.35 %
5.27 %
4.93 %
4.98 %
4.96 %
5.72 %
7.83 %
7.37 %
7.28 %
7.65 %
7.81 %
No of Share Holders
0
1,993
2,301
3,681
3,674
3,573
3,620
3,678
3,901
4,521
4,609
4,625
4,627
4,635
6,315
7,507
6,840
7,511
8,018
8,121
7,976
7,906
8,120
8,749
8,443
8,400
8,903
9,598

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 1 0.65 0.66 0.7 0.7 0.7 0.7 0.7 0.7
Dividend Yield (%) 1.26 0.71 1.67 0.43 0.23 0.27 0.29 0.31 0.13 0.05

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Sept 2021 DIVIDEND Dividend
₹ 0.70 /share
16 Sept 2021 138.57 151.48
22 Sept 2023 DIVIDEND Dividend
₹ 0.70 /share
22 Sept 2023 295.50 291.88
18 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
18 Jan 2024 290.68 279.23
23 Sept 2024 DIVIDEND Dividend
₹ 0.70 /share
23 Sept 2024 327.21 255.86
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 262.73 251.88
26 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Oct 2024 258.23 242.28
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 233.56 240.61
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 241.51 257.00
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 286.73 319.53
23 Sept 2025 DIVIDEND Dividend
₹ 0.70 /share
23 Sept 2025 257.21 405.58
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 403.96 436.50
22 Oct 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
22 Oct 2025 435.50 553.59
08 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2025 574.43 517.09
09 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2026 496.50 549.33
16 Feb 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
16 Feb 2026 498.48 606.01
25 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 May 2026 796.84 842.94
23 Jun 2026 DIVIDEND Dividend
₹ 0.70 /share
23 Jun 2026 842.94 859.14
30 Jun 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jun 2026 769.61 911.86
16 Jul 2026 BONUS Bonus
2:1
16 Jul 2026 878.34 942.19
05 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Aug 2026 907.20 1,109.75

Announcements

Announcement under Regulation 30 (LODR)-Allotment2 days ago
Board Meeting Outcome for Allotment Of 271200 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 08, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 04, 2026
Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.Aug 17, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 17, 2026
Statement Of Deviation Or Variation For The Quarter Ended June 30 2026Aug 14, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2026
Outcome Of The Board MeetingAug 05, 2026
Board Meeting Outcome for Outcome Of The Board MeetingAug 05, 2026
Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Wednesday 05Th August 2026.Jul 30, 2026
Announcement under Regulation 30 (LODR)-AllotmentJul 17, 2026
Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issue Of Bonus Equity Shares.Jul 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 30, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMJun 30, 2026
Closure of Trading WindowJun 24, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 10, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 09, 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").Jun 08, 2026
Intimation Of Record Date For The Purpose Of Final Dividend For The Financial Year 2025-26Jun 08, 2026
Notice Of Book Closure For The Purpose Of 39Th Annual General Meeting (AGM).Jun 08, 2026
Notice Convening 39Th Annual General Meeting (AGM) Of Fredun Pharmaceuticals LimitedJun 08, 2026
Reg. 34 (1) Annual Report.Jun 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 06, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 25, 2026
Revised Outcome.May 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 25, 2026
Audited Results For The Quarter And Year Ended On 31St March 2026.May 25, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May 2026May 25, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 15, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026May 15, 2026
Board Meeting Intimation for The Meeting To Be Held On Monday 25 May 2026.May 15, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2026

Technical Indicators

RSI(14)
Neutral
39.94
ATR(14)
Less Volatile
77.98
STOCH(9,6)
Neutral
31.63
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Downtrend And Accelerating
-12.97
WillR(14)
Neutral
-67.75